Previous Close | 6.82 |
Open | 6.82 |
Bid | 6.49 x 500 |
Ask | 6.55 x 400 |
Day's Range | 6.48 - 6.88 |
52 Week Range | 1.28 - 16.24 |
Volume | |
Avg. Volume | 1,029,296 |
Market Cap | 460.153M |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Insights into Nkarta's Financial Health and Strategic Developments in Cell Therapy
Nkarta stock surged Monday — partially reversing a 31% dive on Friday — after unveiling promising test results for its lymphoma treatment.